← SynDRA
AZD-8186
SynDRA canonical compound SYN0038137 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PIK3CB | PIK3CD |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PIK3CB INHIBITOR
- PI3-kinase p110-beta subunit inhibitor
- PIK3CD INHIBITOR
- PI3-kinase p110-delta subunit inhibitor
- PI3K inhibitor
- PIK3CG INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PIK3CA
- SYK
- TOP2B
- ERN2
- AAK1
- PDXK
- PIM1
- PHKG2
- PFKP
- PDGFRB
- PAK6
- PAK4
- PAICS
- OPA1
- NUAK2
- NTRK1
- PIP4K2A
- PIP4K2C
- NLK
- PKMYT1
- PKN1
- PKN2
- PLK4
- PRKAA1
- PRKACA
- PRKACB
- PRKACG
- PRKAG1
- PRKAG2
- PRKCA
- PRKCB
- PRKCD
- PRKCI
- NQO2
- NEK3
- NEK9
- PRKD3
- MAP4K5
- MAPK1
- MAPK10
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- KSYK
- NSD2
- PIK3R1
- PK3CA
- PK3CG
Cross-references
Synonyms
- AZD8186
- AZD 8186
- AIQ4OWD0RA
- UNII-AIQ4OWD0RA
- CHEMBL3408248
- 8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide
- SCHEMBL1636956
- GTPL8527
- MolPort-039-137-739
- EX-A1649
- BDBM50070322
- s7694
- AKOS025404922
- ZINC116734639
- CS-4975
- ACN-037528
- SB16709
- KS-0000063L
- AK174916
- AC-29024
- HY-12330
- KB-334360
- B5950
- UNII-AIQ4OWD0RA;
- RefChem:116019
- MFCD27987908
- A1EQ4
- orb1300480
- AZD 8186 [WHO-DD]
- C24H25F2N3O4
- GLXC-90324
- AZD8186?
- NSC777572
- NSC799352
- CCG-269309
- EBC-157198
- NSC-777572
- NSC-799352
- NCGC00475728-03
Look up AZD-8186 in the interactive SynDRA portal →